Physician profile
Thomas K Conner
NPI 1780619023
$2,585.21
in general payments reported to CMS, 2019-2025
35 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $96.72 · 2021: $181 · 2022: $339 · 2023: $675 · 2024: $623 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,637.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $825.05 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.27 | 2019-2024 | Jardiance, Synjardy |
| Lilly USA, LLC | $191.21 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $182.16 | 2019-2025 | |
| Glaxosmithkline, LLC. | $157.30 | 2019-2024 | Shingrix, Bexsero, Arexvy |
| Astellas Pharma US INC | $74.41 | 2023-2025 | Veozah |
| Dynavax Technologies Corporation | $72.68 | 2021-2025 | Heplisav-B |
| Novartis Pharmaceuticals Corporation | $65.24 | 2022-2023 | |
| Gilead Sciences, INC. | $64.66 | 2019-2023 | |
| Medtronic, INC. | $54.84 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Horizon Therapeutics Plc | $53.61 | 2019-2023 | Krystexxa |
| Amgen INC. | $53.59 | 2019 | |
| Corium, LLC | $51.38 | 2024 | Azstarys |
| Axsome Therapeutics, INC. | $48.84 | 2023-2025 | Auvelity |
| Merck Sharp & Dohme LLC | $41.34 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Quidel Corporation | $40.84 | 2019 | |
| Abbott Laboratories | $40.82 | 2024-2025 | Freestyle Libre 3 |
| Seqirus USA INC | $39.23 | 2019-2025 | Fluad, Flucelvax |
| Astrazeneca Pharmaceuticals LP | $36.71 | 2019-2021 | |
| Boston Scientific Corporation | $35.52 | 2020-2024 | |
| Corcept Therapeutics | $29.35 | 2024 | Korlym |
| Novo Nordisk INC | $26.65 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $25.95 | 2019-2022 | |
| Treace Medical Concepts, INC. | $18.59 | 2024 | |
| Idorsia Pharmaceuticals US INC | $17.30 | 2022 | |
| Inspire Medical Systems, INC. | $16.68 | 2025 | Inspire |
| Sonex Health, INC. | $16.64 | 2025 | Sx-One Microknife |
| Bayer Healthcare Pharmaceuticals INC. | $16.29 | 2022 | |
| Daiichi Sankyo INC. | $15.29 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $15.20 | 2020 | |
| Endo Pharmaceuticals INC. | $14.60 | 2019 | |
| Genentech USA, INC. | $14.51 | 2019 | |
| Axonics, INC. | $13.20 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.86 | 2022 | |
| Organon LLC | $11.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.